Etienne Montagut serves as Chief Business Officer. He joined Lantheus as SVP, Corporate Development in September
2018. Mr. Montagut is responsible for Business Development, Strategic Planning and Portfolio Management, and has responsibility
for Pharma Services and Digital Solutions (EXINI). Mr. Montagut brings to the Company more than 20 years of commercial, portfolio
management and business development experience. Prior to joining Lantheus, Mr. Montagut spent over six years with GE Healthcare
where he held various executive leadership roles, including General Manager, Global SPECT Portfolio & Director of Cardiology
(cross-modality), Executive, Global Leader SPECT Neurology & Cardiology, and as Executive, General Manager Molecular Imaging
Greater China. Prior to GE Healthcare, Mr. Montagut served in roles of increasing scope and responsibility at Ipsen (Euronext: IPN), a
global biopharmaceutical group focused on innovation and specialty care. During his tenure at Ipsen, Mr. Montagut held both commercial
and corporate positions, including Head of Corporate Commercial Development, Business Development & Licensing and Portfolio
Management after building businesses in the fields of oncology, neurology and primary care in geographies including Eastern Europe,
Australia, China and Canada. Mr. Montagut holds a Master of Business Administration from Imperial College, London, and a Master of
Business Intelligence from EGE Paris
2018. Mr. Montagut is responsible for Business Development, Strategic Planning and Portfolio Management, and has responsibility
for Pharma Services and Digital Solutions (EXINI). Mr. Montagut brings to the Company more than 20 years of commercial, portfolio
management and business development experience. Prior to joining Lantheus, Mr. Montagut spent over six years with GE Healthcare
where he held various executive leadership roles, including General Manager, Global SPECT Portfolio & Director of Cardiology
(cross-modality), Executive, Global Leader SPECT Neurology & Cardiology, and as Executive, General Manager Molecular Imaging
Greater China. Prior to GE Healthcare, Mr. Montagut served in roles of increasing scope and responsibility at Ipsen (Euronext: IPN), a
global biopharmaceutical group focused on innovation and specialty care. During his tenure at Ipsen, Mr. Montagut held both commercial
and corporate positions, including Head of Corporate Commercial Development, Business Development & Licensing and Portfolio
Management after building businesses in the fields of oncology, neurology and primary care in geographies including Eastern Europe,
Australia, China and Canada. Mr. Montagut holds a Master of Business Administration from Imperial College, London, and a Master of
Business Intelligence from EGE Paris
Speaking In
4:00 PM - 4:15 PM
Wednesday, June 7
